What kind of medicine is umbralisib?

Ukoniq Albliside is marketed as an anticancer drug for the treatment of marginal zone lymphoma(MZL) and follicular lymphoma(FL). Albreeze (UKONIQ)isTG TherapeuticsThe first oral bisphosphatidylinositol3-kinase delta(PI3Kδ)and casein kinase1ε(ck1ε) inhibitors for the treatment of various hematological malignancies. In 2021February , Albrixide was approved for the first time in the United States for the treatment of patients with ≥ 1Relapsed or refractory marginal zone lymphoma(MZL) based on anti-CD20 regimen and previously received ≥ 3relapsed or refractory follicular lymphoma(FL) after systemic therapy. Clinical studies in various hematologic malignancies, including chronic lymphocytic leukemia and non-Hodgkin lymphoma, are ongoing in multiple countries. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.